TGTX - TG Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts5565
Avg. Estimate-0.41-0.39-1.57-1.29
Low Estimate-0.48-0.48-1.83-1.61
High Estimate-0.3-0.29-1.3-0.87
Year Ago EPS-0.59-0.43-2.3-1.57
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts5555
Avg. Estimate20k20k130k23.7M
Low EstimateN/AN/AN/A200k
High Estimate40k40k200k53M
Year Ago Sales38kN/A152k130k
Sales Growth (year/est)-47.40%N/A-14.50%18,130.80%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.53-0.54-0.44-0.43
EPS Actual-0.59-0.43-0.69-0.43
Difference-0.060.11-0.250
Surprise %-11.30%20.40%-56.80%0.00%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.41-0.39-1.57-1.29
7 Days Ago-0.41-0.39-1.57-1.29
30 Days Ago-0.41-0.39-1.58-1.32
60 Days Ago-0.42-0.4-1.59-1.35
90 Days Ago-0.38-0.36-1.55-1.49
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days2332
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesTGTXIndustrySectorS&P 500
Current Qtr.30.50%N/AN/A0.02
Next Qtr.9.30%N/AN/A0.04
Current Year31.70%N/AN/A0.05
Next Year17.80%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A